The Worldwide Market for In Vitro Diagnostic Tests

Questions: Discounts, Updates etc.

Pages: 1000

Price (Single): $4995

Price (Departmental):

Price (Company): $9990

Publication Date: 2008-01-17

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

This report offers comprehensive and indispensable coverage of the breadth of traditional in vitro diagnostic testing. The report contains complete market statistics and analysis for all areas of in vitro diagnostic, including:

Market size, growth, share, and geographic distribution, as well as trends in technology development, regulatory and reimbursement issues, clinical care, and business environments are discussed. Projections are made through 2012.

The report is a rewrite of a 1997 report.

Expanded Coverage in This New Edition

This new 1,100-page edition greatly expands coverage of the field and tracks the most important developments. Expanded or added in this edition are sections on:

In addition, there are now profiles of established and emerging players in IVD, more than 276 companies, from the top tier to emerging and niche competitors to watch.

As part of its coverage, the report breaks down the in vitro diagnostic market for the following regions.

A New Report Design for a Changing Industry

This report has reorganized the presentation of the in vitro diagnostic market in a manner that better reflects how the industry has evolved since the first edition was published in 1997. At that time, molecular testing was a small emerging discipline that related to chlamydia, gonorrhea, TB, and some inherited diseases. That first edition didn’t even have a chapter for molecular diagnostics; it was a miscellaneous. Now, molecular tests are common in several segments - infectious diseases, bacterial identification, coagulopathologies, blood unit screening, histology and soon as POC devices. Therefore the molecular chapter in this report presents technology and market issues that are common to all segments and concentrates on purely molecular tests for inherited diseases. Molecular tests used in other segments are included in the appropriate chapter. In 1997, POC testing meant glucose testing. Similar to molecular testing, rapid and POC tests are becoming an important part of testing on all fronts. Here too the POC chapter presents technology and market issues that are common to all segments and concentrates on blood glucose monitoring.

The multisegment core lab has become a reality. The chemistry lab is the hub of some 80% of the routine test workload. Thus a new chapter: Core Lab that will include clinical chemistry.

 

Age of the Giants (and Smaller Colossuses)

Since 2000 or so in vitro diagnostics manufacturers have introduced a new generation of immunoassays and molecular tests that have renewed industry growth. In the past 2-3 years, several product innovators have seen their annual revenues double and triple, while some of the top in vitro diagnostics companies experienced negative growth or sluggish single digit revenue increments.

The mix of established distribution experts and newer products and technologies has resulted in numerous acquisitions and marketing alliances.

Table of Contents

Chapter one: Executive Summary

Chapter two: Introduction

Chapter three: Overview of Global  In Vitro Diagnostic Markets

CHAPTER FOUR: TRENDS AND INNOVATIONS:

CHAPTER FIVE: Point-of-Care Tests

chapter six: The Core Lab

chapter seven: Immunoassays

chapter eight: Molecular Assays

chapter nine: Hematology

chapter TEN: Coagulation

chapter eleven: Microbiology and Virology

chapter twelve: Blood Banking Services

chapter thirteen: Histology and Cytology

 

Table of Exhibits
CHAPTER ONE: Executive Summary

CHAPTER TWO: Introduction

CHAPTER THREE: OVERVIEW OF WORLD IVD MARKETS

CHAPTER FIVE: Point-of-Care Tests

CHAPTER SIX: THE CORE LAB

CHAPTER SEVEN: IMMUNOASSAYS

CHAPTER EIGHT: Molecular Assays

CHAPTER NINE: Hematology

CHAPTER TEN: Coagulation

chapter eleven: Microbiology and Virology

CHAPTER TWELVE: Blood Banking Services

chapter thirteen: Histology and Cytology

Other users found this report page using the following search terms: in vitro diagnostics ivd pcr molecular diagnostics Point-of-Care poc Core Lab Immunoassays Molecular Assays Histology Cytology market diagnostic vitro diagnostics ivd worldwide share test immunoassay 2007

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.